PEG-ara-c derivatives (Enzon)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePEG-ara-c derivatives (Enzon)
Drug Alias NamePEGylated cytarabine derivatives (Enzon)PEGylated cytosine arabinoside derivatives (Enzon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnzon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A